In June 2020, BSV formed a strategic alliance with LaVoieHealthScience in order to enhance BSV's capabilities to communicate value. <read more here>                     In May 2020, BSV entered into a strategic alliance with FCF Fox Corporate Finance to support funding activities. <read more here>                    
                           COVID-19 Portal               Home      About      Team      Clients      Publications      Downloads      News      Career      Contact

  With the dedicated support, and particularly the experienced, constructive work of Bioscience Valuation, we accomplished meaningful results that provide important new knowledge enabling our next steps in diabetes research. We sincerely thank the entire Bioscience Valuation team for their valuable and straightforward collaboration in the past year, and look forward to the next opportunity of working with them again.

Prof. Dr. Thomas Danne, Director, and Dr. Bärbel Aschemeier, Clinical Research, AUF DER BULT Hospital for Children and Adolescents


Core Services
  Financial Valuation
  Commercial Assessment &

  R&D Risk Analysis &
Productivity Increase

  Portfolio Management
  Investment Decisions
  Partnering / Licensing
  Corporate Finance / M&A

Special Expertise
  Economic Modeling
of Healthcare Systems

  Assessing the Economics
of Personalized Medicine

Comprehensive Support
  Corporate Partnership Program

  Market Model
  R&D Risk Model
  Valuation Model

Bioscience Valuation's Publications

GREUEL, J., BODE-GREUEL, K., LOESER, T. (2020) Creating unique equity stories - Meeting the standards of US capital markets. In CAPITAL MARKET & INVESTMENT 01-2020. P.42-43

BODE-GREUEL, K. & RIMPLER, M. (2019) Einsatz künstlicher Intelligenz in der Versorgungsforschung und Kommerzialisierung. Pharm. Ind. 81(6). P.766-772

GREUEL, J. (2017) Portfolio Planning and Risk Management in the Pharmaceutical Industry 1. In THE BIOMEDICAL & LIFE SCIENCES COLLECTION. London: Henry Stewart Talks Ltd.
(Online at

GREUEL, J. (2017) Portfolio Planning and Risk Management in the Pharmaceutical Industry 2. In THE BIOMEDICAL & LIFE SCIENCES COLLECTION. London: Henry Stewart Talks Ltd.
(Online at

GREUEL, J. (2016) The Role of Modern Portfolio Management in Pharma Innovation. In SCHUHMACHER, A., HINDER, M. & GASSMANN, O. (eds.). Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA. p.449-458.

NICKISCH, K. & BODE-GREUEL, K. (2016) Biosimilars Or Biobetters: Make Your Decisions Wisely. Research & analysis Journals. 2 (8). p.530-535.

BODE-GREUEL, K. & NICKISCH, K. (2014) Deciding between biobetter versus biosimilar development options based on net present value calculations. Journal of Commercial Biotechnology. 20 (2). p.21-31.

NICKISCH, K. & BODE-GREUEL, K. (2013) NPV modelling for the selection of value-creating biosimilar development candidates. Journal of Commercial Biotechnology. 19 (1). p.24-32.

SCHRÖDER-BERNHARDI, D., ENGELHARD, J., WANG, Y., BUSCH, S., BODE-GREUEL, K. (2016) Ein nationales Typ-2-Diabetes-Register. Pharm. Ind. 78(3). P.324-330

BODE-GREUEL, K. (2011) Management strategischer und operativer Risiken in der Arzneimittelentwicklung. Pharmazeutische Medizin. 13 (3). p.178-183.

BODE-GREUEL, K. & WAGNER, C. (2011) Consultants' Perspectives: Bioscience Valuation.
Focus Oncology. 3. p.13-17.

BODE-GREUEL, K. (2010) Optimierung der Risikostruktur klinischer Engtwicklungsprojekte. DGPharMed News. 12 (3). p.111-115.

BODE-GREUEL, K. & GREUEL, J. (2010) Bewertung von Biotech-Unternehmen. In DRUKARCZYK, J. & ERNST, D. (eds.). Branchenorientierte Unternehmensbewertung. 3rd Ed., Munich: Verlag Franz Vahlen. p.293-308.

BODE-GREUEL, K., GREUEL, J. and NICKISCH, K. (2009) How can pharmaceutical and biotech companies maintain a high profitability? Journal of Commercial Biotechnology. 15 (4). p.309-323.

BODE-GREUEL, K. & NICKISCH, K. (2008) Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development - Commonalities and differences in portfolio management practice. Journal of Commercial Biotechnology. 14 (4). p.307-325.

GREUEL, J. (2008) Pharma and Biotech: Is it possible to continue growing? Pharma Focus Asia. 6. p.6-9.

GREUEL, J. (2005) Assessing the economics of biogenerics. Journal of Generic Medicines. 2 (2). p.153-160.

BODE-GREUEL, K. & GREUEL, J. (2005) Determining the value of drug development candidates and technology platforms. Journal of Commercial Biotechnology. 11 (2). p.155-170.

GREUEL, J. (2002) The R&D value conundrum. Current Drug Discovery. July. p.37-42.

LOCH, C. & BODE-GREUEL, K. (2001) Evaluating growth options as sources of value for pharmaceutical research projects. R&D Management . 31 (2). p.231-248.

BODE-GREUEL, K. (2000) Real Options Evaluation in Pharmaceutical R&D: A New Approach to Financial Project Evaluation. SCRIP Reports. BS1038, 17th February. London: PJB Publications Ltd.

BODE-GREUEL, K. (1998) Making wise decisions in pharmaceutical investment. Scrip Magazine. June. p.27-28.

BODE-GREUEL, K. (1997) Financial Project Evaluation and Risk Analysis in Pharmaceutial Development. SCRIP Reports. BS890, 27th November. London: PJB Publications Ltd.

Scientific Publications - Bioscience Valuation

KLISCH, J., BODE-GREUEL, K., HORVÁTH, E., KLISCH, C. and ELS, T. (2003) Additive neuroprotective effect of Ketanserin and Ipsapirone on the hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. Neurosci Lett. 15th May. 342 (1-2). p.25-28.

DE VRY, J., SCHOHE-LOOP, R., HEINE, H., GREUEL, J., MAULER, F., SCHMIDT, B. and GLASER, T. (1998) Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. Journal of Pharmacology and Experimental Therapeutics. 284 (3). p.1082-94.

SOMMERMEYER, H., SCHREIBER, R., GREUEL, J., DE VRY, J. and GLASER, T. (1993) Anxiolytic effects of the 5-HT1A receptor agonist ipsapirone in the rat: neurobiological correlates. Eur J. Pharmacol. 10th August. 240 (1). p.29-37.

SIRETEANU, R., SINGER, W., FRONIUS, M., GREUEL, J., BEST, J., FIORENTINI, A., BISTI, S., SCHIAVI, C. and CAMPOS, E. (1993) Eye alignment and cortical binocularity in strabismic kittens: a comparison between tenotomy and recession. Vis Neurosci. May-June. 0 (3). p.541-9.

KLISCH, J. & BODE-GREUEL, K. (1992) Ketanserin reduces neuronal calcium accumulation and cell death in the hippocampus of the Mongolian gerbil after transient forebrain ischemia. Brain Res. 24th April. 578 (1-2). p.1-7.

GREUEL, J., GLASER, T. (1992) The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur J Pharmacol. 11th February. 211(2). p.211-9.

BODE-GREUEL, K. & SINGER, W. (1991) Development changes of calcium currents in the visual cortex of the cat. Exp Brain Res. 84 (2). p.311-8.

BODE-GREUEL, K., KLISCH, J., HORVÁTH, E., GLASER, T. and TRABER, J. (1990) Effects of 5-hydroxytryptamine1A-receptor agonists on hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. Stroke. 21st December (12 Suppl). IV. p.164-6.

LUHMANN, H., GREUEL, J., SINGER, W. (1990) Horizontal Interactions in Cat Striate Cortex: II. A Current Source-Density Analysis. Eur J. Neurosci. 2 (4). p.358-368.

LUHMANN, H., GREUEL, J. and SINGER, W. (1990) Horizontal Interactions in Cat Striate Cortex: III. Ectopic Receptive Fields and Transient Exuberance of Tangential Interactions. Eur J. Neurosci. 2 (4). p.369-377.

BODE-GREUEL, K., SINGER, W. (1989) The development of N-methyl-D-aspartate receptors in cat visual cortex. Brain Res Dev Brain Res. 1st April. 46 (2). p.197-204.

GREUEL, J., LUHMANN, H. and SINGER, W. (1988) Pharmacological induction of use-dependent receptive field modifications in the visual cortex. Science. 7th October. 242 (4875). p.74-7.

BODE-GREUEL, K., SINGER, W. (1988) Developmental changes of the distribution of binding sites for organic Ca2+-channel blockers in cat visual cortex. Exp Brain Res. 70 (2). p.266-75.

GREUEL, J., LUHMANN, H. and SINGER, W. (1987) Evidence for a threshold in experience-dependent long-term changes of kitten visual cortex. Brain Res. July. 431 (1). p.141-9.

ALTMANN, L., LUHMANN,H., GREUEL, J., SINGER, W. (1987) Functional and neuronal binocularity in kittens raised with rapidly alternating monocular occlusion. J. Neurophysiol. November. 58 (5). p.965-80.

BODE-GREUEL, K., SINGER, W. and ALDENHOFF, J. (1987) A current source density analysis of field potentials evoked in slices of visual cortex. Exp Brain Res. 69 (1). p.213-9.

This website uses cookies to ensure you get the best experience on our website.
Privacy Policy